NewsBenzingaXtant Medical Hldgs、第3四半期EPSは(0.03)ドルで、予想の(0.02)ドルを下回る。売上高は2,428.5万ドルで、予想の2,551.2万ドルを下回る。 Xtant Medical Hldgs、第3四半期EPSは(0.03)ドルで、予想の(0.02)ドルを下回る。売上高は2,428.5万ドルで、予想の2,551.2万ドルを下回る。 Benzinga 2026.11.16 12:03 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3